30 May 2014 07:00
e-Therapeutics plc
Notice of Annual General Meeting and Annual Report
Oxford and Newcastle, UK, 30 May 2014- e-Therapeutics plc (AIM: ETX) announces that its annual report and accounts for the year ended 31 January 2014, which includes the notice convening the Company's 2014 Annual General Meeting (AGM), has been posted to shareholders today. The annual report is available for electronic download from the Company's website, www.etherapeutics.co.uk.
The 2014 AGM will take place at the offices of Bond Dickinson LLP at St Ann's Wharf, 112 Quayside, Newcastle upon Tyne NE1 3DX at 11.00am on Wednesday 9 July 2014.
- Ends -
Contacts:
e-Therapeutics plc
Steve Medlicott, Finance Director
Tel: +44 (0) 1993 883125
www.etherapeutics.co.uk
Panmure Gordon (UK) Limited
Fred Walsh / Duncan Monteith
Tel: +44 (0) 20 7886 2500
www.panmure.com
Instinctif Partners
Melanie Toyne-Sewell / Stefanie Bacher
Tel: +44 (0) 20 7457 2020
Email: e-therapeutics@instinctif.com
About e-Therapeutics
e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company's discovery and development activity is focused in cancer and disorders of the nervous system.
e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company please visit www.etherapeutics.co.uk.